A rare brain disease can look completely different from one person to the next. But a particular pattern on a brain scan may provide a crucial clue—sometimes before doctors know what they are seeing. Neuronal intranuclear inclusion disease is a rare, progressive condition in which abnormal deposits build up inside cells throughout the brain, nerves, automatic body-control systems, and some organs.

Its symptoms are highly varied: they may involve the brain, the nerves outside it, or the body’s automatic control systems. The adult form is categorized into familial and disseminated types based on genetic characteristics. The problem is that clear diagnostic criteria for this disease have not yet been established.

Doctors mainly look for three clues: a characteristic bright signal in a particular area of a brain scan, abnormal deposits in a skin sample, or an unusual repeated stretch in a gene. The scan clue is especially useful because it is the strongest and most readily available evidence for deciding whether to pursue further testing.

Early recognition therefore matters. The study set out to describe the disease’s symptoms and brain images, search for scan features linked specifically to it, and track how those scan changes shift over time. The larger goal was to understand which changes in the brain’s wiring and tissue might help explain the disease and improve early, accurate diagnosis.

Here is the visual clue: the most characteristic brain-scan finding was a curved bright signal where the brain’s outer wiring meets its deeper tissue. A typical lace-like pattern appeared in most patients, usually near the front of the brain.

In most of those cases, it was evenly spread from side to side. But the pattern was not universal: some patients had an asymmetric signal in one frontal lobe, while others showed high signals across extensive white-matter areas. Some patients also had changes in the cerebellum, including two with high signals there and no other abnormal imaging findings.

These brain scans reveal a recognizable pattern: a bright, lace-like rim where the brain’s wiring meets its outer layer, often alongside widespread tissue loss and damaged connections. Yet one person lacked that usual rim, showing why this clue can support diagnosis but cannot rule the disease out alone.

The signal also changed over time. In some patients it stayed present or gradually became stronger as the disease progressed. In several cases, the signal disappeared during follow-up. Others showed no significant change at all, suggesting that the scan does not follow one simple timetable.

Across the group, impaired thinking was the most prominent clinical feature, although some people first had brief, episodic symptoms instead. The bright signal near the brain’s outer wiring remained the most typical imaging finding, but it followed four different patterns as the disease progressed.

Changes in the connecting bridge between the brain’s halves and in the cerebellum may appear early. There is an important caution: the group studied was limited, and neuropsychological assessment information was incomplete for some patients in the study.

The tests used may also miss parts of a person’s cognitive profile, especially in younger people, because the study relied on the MMSE and MoCA scales. The study group was small, so larger studies are needed to learn whether these findings hold across diverse patient groups.

Longer-term tracking of functional brain imaging was also missing, leaving the study without longitudinal follow-up of how brain function changed over time. The study found that this disease often affects thinking, yet its most recognizable clue is a distinctive bright pattern near the brain’s outer edge.

Recognizing that pattern could help people reach the right diagnosis sooner.